Introduction
Picolinic acid (PA), a tryptophan metabolite, is a bidentate chelating agent which appears to be active in zinc metabolism. A number of recent studies have shown that orally achninistered PA improves intestinal absorption of zlnc in experimental animals (4, 9, 14, 17) . Complexed with zinc, it decreased the zinc requirements of three patients with acrcdemtitis enteropathica (AE) to one-third (2) and improved zinc absorption in men with pancreatic insufficiency as opposed to men with cirrhosis of the liver (1): moreover, the PA content of pancreatic extract appeared to be one explanation of the effectiveness of this medication in three patients with variant AE (13, 15) . Several other studies have not shown an effect of PA at the intestinal site. The reason for these inconsistencies appears to be related to the zinc concentration of the medium. This was suggested by tm recent studies, which demonstrate that PA and other ligands are effective in raising tissue or plasma zinc lf dietary zinc intake is low (9, 14) .
Accordinq to Rehello g g . (19) . PA concentration in milk is similar to nicotinic acid, ahout 5 ma. Using a different method, Evans gtg. (4) obtained substantially higher values, especially in human milk. Concentration in plasma is 12 mcM (2, 15) , sufficient to bind threevarters of circulating zinc. This Dresence of PA in Dlasma suuuests that it serves a function at sites other ' t h a n the intestinai m~cosa;~kreover, certain observations in variant AE originally led us to speculate that PA facilitates zinc transport at peripheral tissue sites or enhances zinc binding to metalloenzymes (12). We studied therefore the effect of PA when added to tissue culture of diploid fibroblasts. This required characterization of the zinc transport mechanism in human fibroblasts, which had not been done. Our methodology of using fibroblasts grown on coverslips for transport studies has been used before only in the study of amino acid transport (8) .
The results of our zinc transport studies and of the effect of PA and other lisands fom. the basis of this remrt. Whereas PA seem^ to enhance the uwtake of zinc by the intestinal mucosa under certain conditions (4, 14, 17) , we found that it inhibits transport of zinc into fibroblasts.
Materials and Methods
Human diploid fibroblasts from fetal tissue (subcultures limited to less than 12) were grown in Eagles essential medium (25), containing 10% fetal calf serum, penicillin (100 U/ml) and streptomycin (100 mcg/ml). Transport studies were conducted on cells g m on washed sterile coverslips (11 x 22 mn) (26).
The seeding and incubation procedure was essentially that of Foster and Pardee (8) . With fibroblasts near confluency, coverslips were rinsed twice with phosphate-buffered saline-glucose (PBSG) (27), containing 130 mY NaC1, 5 mY KC1, 1.2 rit.3 M~S O , one mM CaCl , 5 nM glucose and 10 mY Na HPO (pH 7.4). The coverslips were ?eft in the fiaal PBSG wash for one h at 3Z0c 48). It was assumed that this step minimizes endogenous zinc concentration. Cell viability appears unaffected (8) . Because maximum density of mnolayered cells may decrease the accumulation rate of essential nutrients we utilized coverslips with evenly distributed cells that had not quite reached confluency. Some interassay variability of zinc uptake was probably due to inability to duplicate the state of confluency. The incubation medium for t +~ transport studies contained PBSG, ZnCl (5 to 40 mcM) and 0.05 uCi/ml of [ znJ(30) . in a total volume of 25 ml. ~ncdations were carried out at 3 7 O~ for time periods ranging from 30 sec to 20 min, uslng 50 ml disposable polypropylene beakers (28) and a holding rack (29) . After incubation, coverslips were dipped six times into separate solutions of cold saline, using a holding rack. Drained coverslips were placed separately into glass scintillation vials. After mixture with 75 mcl distilled water and 400 mcl soluene-350 (31), fibroblasts were solubilized by heating for 30 -45 min at 4 5 ' . Scintillation fluid (32) (10 m1)was added and radioactivity counted in a Packard Tricarb Liquid Scintillation Spectrometer, Model 3385 (31) . efficiency 36%. Zinc uptake by fibroblasts was calculated from the specific radioactivity of the zinc in the medium. Zinc uptake was related to the average protein content per coverslip, which was determined for each assay from several coverslips of each culture disk. The protein content, which was shown to reflect cell number (8) , ranged between 50 -80 mcq per coverslip. The effect of PA on zinc uptake by fibroblasts was studied by adding PA to the incubation mixtures in concentrations ranging from 20 -100 mcM. The effect of other zinc binding ligands, citric acid, and histidine (100 ma), and of metabolic inhibitors, KCN (one mY) and ouabain (one mM), was also studied. Protein was determined by the Lowry dification of the Folin-Ciocalteu method (16). ratio of 1:10 ( Fig. 3) . Inhibition by PA was greater on an equinalar basis than that of citric acid or histidine. The inhibitory effect of PA at the 1:10 ratio was the same during phase I and I1 of zinc uptake (60%). At low PA concentrations, inhibition of phase I1 uptake was in a similar high range whereas phase I uptake was only minimally affected, 7% inhibition at a zinc: llaand ratio of 1:2 (Table 2) . A Dixon olot was constructed, usinq 5-min in-A t i o n s and PA as the inhhitor in concentrations of 20 -80 mcM: Inhibition was linear over the indicated PA concentrations range (Ki 12.5 mcM).
Discussion
Detailed studies of the kinetics of zinc transport have been performed in the past in hepatocytes (7, 22) , HeLa cells (3), leucocytes (ll), lywhocytes (la), and microorganisms (6) . Mouse fibroblasts were used by Schwarz and Matrone (20) , who studied the effect of amino acids, albumin, and citrate on zinc transport. S u g m and Munro (24) used human fibroblasts when they tested the effect of age on zinc accumulation. The kinetics of the uptake mechanism were not investigated in either of these fibroblast studies. It appears, therefore, that our report is the first detailed investigation using human fibroblasts. Because this tissue is readily accessible to h w s , it may beame useful in investigations of genetic disorders of trace metal metabolism.
Our findings show that the mechanism of uptake is similar to that in hepatocytes (7, 22) and leukocytes (ll), in that it occurred in t w phases, one early phase of rapid uptake, followed by a phase of slower uptake. The relation between the velocity of uptake and substrate concentration indicates that the early phase is saturable and, therefore, apparently carrierdiated. Zinc uptake during the second phase appears to be passive.
Data on the effect of metabolic inhibitors on zinc transport in hepatocytes is conflicting. Failla and Cousins (7) showed that inhibitors of oxidative metabolism decreased the m u n t of acumNlated zinc, whereas Stacey and Klaassen found no effect by KCN (22) . In our studies, KCN inhibited zinc uptake by 62% during the first 2 min. The effect tapered off after the early phase to 26% between 2 -10 min of incubation, with no further increment in inhibition after 10 min. These reported inconsistencies have been attributed to the abil~ty of the CN group to bind zinc, however, analogous to the PA effect, KCN inhibition should have affected phase I1 m r e than phase I if this were the case. Guabain had no inhibitory effect, indicating that zinc transport does not require A m , a fact which is cmptible with operation of a carrier-mediated transport mechanism during phase I.
PA acted (in vitro) as a powerful inhibitor of zinc uptake, especially during phase 11, when a Zn:PA ratio of one:tw caused 75% inhibition. In general, inhibition of passive uptake suggests that the inhibitor does not ccmpete with a carrier. This appears to be the case with PA, which is a known chelating agent. The inhibitory effect of PA during phase I thus may be expressed as "competition" between PA and the carrier for free zinc in the medium, with which PA £ o m a stable complex. Such "quasi" inhibition may explain why we were able to obtain on the Dixon plot an inhibitory constant, indicative of a canpetitive d e of inhibition. An alternate, though less likely explanation, is the existance of "true" mmpetition between zinc and the Zn:PA complex for the carrier.
Assming a physiologic role for PA, these data shav that it's effect would be entirely different at finroblast membranes of peripheral tissues than the effect observed by s m investigators at intestinal transport sites. Zn:PA ccgnplex given orally to a patient with AE (2), variant AE (12, 13) and pancreative insufficiency (1) improved zinc absorption. Uncomplexed PA given orally to rats also inproved intestinal absorption of zinc (4, 9, 14, 171 although the effect may be limited to low zinc concentrations (9, 17) . Our studies now show that the characteristics of the Zn:PA complex make PA suitable to function both as a compound that p m t e s zinc absorption and prevents entry into intestinal tissues after it is absorbed. As such, PA could facilitate distribution of zinc and prrmote its conservation (5).
Whether PA functions indeed as a trace metal carrier in body fluids is not known, because current methods for measuring PA do not distinguish between free and complexed PA and different investigators disagree over the actual m u n t of PA that they found in physiologic fluids, mainly human milk (4, 19) and pancreatic excretions (10, 13). Hurley and L&nnerdal (10) therefore believe that the effect of PA is nonspecific and metabolically unimportant. This study of the in vitro effect of PA on fibroblast uptake of zinc shows that PA m y be important as a ligand, along with others, if it is present in plasma in the m u n t s indicated. A m r e important role may be anticipated in the kidney, providing the zinc-PA complex is filtered through the gl~erulus, especially because albumin is not filtered and PA is a stronger ligand than histidine, generally considered to be the strongest m n g amino acids. Assuming sirmlar characteristics of the Zn:PA complex at the renal tubular site as in intestine, PA could be responsible for the reabsorption of zinc. A role A<xa.,A La for PA in renal control of zinc metabolism is also suggested by the finding of In studies relating zinc uptake to the time of incubation, rapid uptake ocdisproportionately high activities of picolinic acid carboxylase, the enzyme curred durins the first 2 min (phase I) and was followed bv slower uwtake responsible for PA formation, in renal tissue (23). (phase 11). The rate of zinc uptake increased with increasing zinc concentrations in the medium (Fig. 1) . At concentrations of 20 -40 mcM, zinc accumulation continued to lncrease throughout the entire incubation period up to a maxirmrm to 5 m l e s Der ma rotei in. After 20 min incubation. saturation was not achieved at the highest-zinc concentration tested (40 mcM): By contrast, at a concentration of 5 mcM, zlnc accumulation leveled off at one m l e s per mg protein after only 1 to 2 min of incubation.
The relation between substrate concentrations and the velocity of uptake was curvilinear during phase I of incubation (0 -2 min). A drastlc change in the early part of phase I1 resulted in a near linear correlation for the period between 2 -10 min of incubation. These findings are indicative of facilltated uptake during phase I.
The possible involvement of an active, energy requiring transport mechanism during any stage of zinc uptake was tested by incubating the cells in the presence of KCN (one mY). In two separate experiments we observed during the first 2 nun of incubation 60 and 62% inhibition of zinc uptake, respectively. During tm longer incubation periods, starting at 2 min and up to 10 and 20 m n , respectively, KCN inhibition was 26%, each (Table 1) . Zinc uptake was not affected by the addition of ouabain (one nM) to the incubation medium.
Addition of uncomplexed PA to food did not affect zinc absorption in our patients with AE although the feeding of Zn:PA cmr@lex was effective (2) . Slmilar observations were made in adult volunteers who were given either PA in aqueous solutions or with meals along with pharmacological doses of zinc (21).
But when the same am3unt of z m c was given in aqueous solutions along with ferrous lon, addition of PA lmproved absorption Of pharmacological doses Of zinc (Zn:PA ratio Of 1:6). It therefore may ke antlclpated that the relation between PA,ccrrptetive trace metals and other ligands, l&e altumin and amino acids, is as c q l e x in plasm and interstitlal fluids as at the intestinal transfer site Because our system did not contain other ligands, known to Ix present in plasma and interstitial fluids, only limted conclusions can be drawn £ran this study. In the h e n c e of these llgands, phase I is rapidly saturated at physiologic zinc concentrations of 10 -20 M, whereas phase I1 uptake continues for considerable time longer than tested in our incubation experinents. Assuming that the true plasma Zn:PA ratio is somewhat higher than the 1:2 ratio tested in Our system, we can expect negligible inhibition during phase I, but a considerable effect during phase 11, which may Ix mprtant for z m c distribution following intestinal absorption and uptake into the portal system. Further studies are necessary to explore these caplex mteractions.
Apparent Km and Umx Values £01 zlnc transport were determined from double re-S -Y ciprocal plots, using short time incubations of 1 and 2.5 min. For 1.0-min mncubation, Km was 8.3 mcM and Vmaw 7.7 mles/mg protein/min. For 2.5 min
The kinetics of zinc transport were studied in hurrwn diploid fibroblasts grown incubation Km was 9.3 mcM; Vmax was 2.3 mles/mg protein/min and decreased on coverslips. Zinc uptake was rapid durlng the first 2 m i n of incubation further with prolongation of the incubation period.
(phase I) and was followed by s l m uptake (phase 11). Zinc uptake was positively correlated with zinc concentrations in the medium. The relation ketween The inhibitory effect of ligands on zinc uptake was compared at a zinc:liqand z m c concentration and velmity of uptake was curvilinear during phase I. A drastic change d w m g the early part of phase I1 resulted m a near linear correlation for the per103 ketween 2 -10 min of mcubation. The metablic inhibitor KCrJ ( one mY ) affected mainly phase I and resulted i n 62% inhibition. Ouabain had no inhibitory effect. These findings are indicative of facilitated uptake during phase I, when a carrier-diated, Fig. 3 and 20 min. The medlum contained 10 rnm zlnc and L~'ZII] tracer (controls).
K a concentration was one rt4. Eke velocity of uptake was calculatod~from the spec~flc raboactlvlty of [ zn] m the medlum.
Zinc uptake by skin fibroblasts, grown on coverslips, in relation to incubation time. The zinc concentration in the medium ranged from 5 to 40 m. Each point represents a mean of four coverslips.
Velocity of zinc uptake by skin fibroblasts in relation to zinc concentration in the medium. Incubation periods were either 0 to 2 or 2 to 10 min. Each point represents an average of two coverslips. 
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Effects of ligands on zinc uptake by skin fibroblasts. Zinc concentration in the medium, was 10 mcM and the concentration of the ligands was 100 mcM. Each point represents the mean of foiir coverslips and +1 S.D. as indicated by E.
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